Grant Thornton advises Bourn Bioscience Limited Bourn Bioscience Limited has been sold to Triangle Capital Corporation

December 2020
Bourn Bioscience Limited
Adviser to Bourn Bioscience on their sale to Triangle Capital Corporation
£undisclosed
Grant Thornton team
  • Peter Jennings
    Peter Jennings
    Head of Private healthcare, Corporate Finance Advisory
Private sector healthcare
Sell side
Corporate finance
Canada
UK

We are delighted to have advised Bourn Bioscience Limited on their sale to Triangle Capital Corporation.

Bourn Hall was founded in 1980 as the world’s first IVF clinic. Since its foundation, the clinic has played a significant role in the creation of over 20,000 families and has continued to grow its market presence in the East of England.  

Our firm were engaged as lead advisers to find new investors to support the next phase of the Company’s growth. 

Bourn Hall had received interest from several parties. Our team ran a multi-funder process to increase competitive tension.  

We led the detailed negotiations, project managing various diligence streams and advised on the key commercial terms of the transaction.  

Triangle were the preferred bidder based on the strong growth aspirations for Bourn Hall. 

We drove a competitive process, managing multiple buyers simultaneously, before entering into exclusivity. This enabled us to negotiate and secure an offer which was maintained through to completion.   

Testimonial

The Grant Thornton team did a great job and we are thankful for their continued support throughout the process. They really went the extra mile for us, which delivered a great result for the Business and the Shareholders.

Michael Macnamee CEO, Bourn Bioscience Limited

Get the latest deal announcements straight to your inbox

Transaction